
The real issue is not whether NIH should study sexual and gender minority birthing people; it already does, and for good reason. The harder question is whether a particular grant is doing ordinary, defensible population health research or merely wearing a politically charged label. On the evidence available, the University of Maryland project fits the first category far more convincingly than the second.
Key Points
- NIH explicitly funds maternal-health research aimed at populations with health disparities, including sexual and gender minority populations.
- The University of Maryland project is framed as a longitudinal mixed-methods study of psychological distress during the perinatal period, with attention to social support and medical care.
- Broader NIH portfolio data show SGM-health research is an established, though still small, part of federal biomedical funding.
- Critics in the record mostly object to wording and public framing; they do not present a protocol-level refutation of the study’s scientific premise.
Why This Grant Exists in the First Place
At its core, this study sits inside a standard NIH problem set: pregnancy, mental health, and disparities. NIH’s maternal-health centers are explicitly designed to address biological, behavioral, environmental, sociocultural, and structural factors affecting pregnancy-related complications and deaths, and the agency says those centers will focus on populations that experience health disparities, including sexual and gender minority populations. That matters because it places the University of Maryland project in a recognizable research tradition, not in some novel category invented for publicity.
The project title itself is dense but straightforward once decoded. It is a longitudinal mixed-methods analysis of the factors that shape psychological distress among sexual and gender minority birthing people throughout the perinatal period. In plain English, it asks how mental health changes from pregnancy through the postpartum period, and how social support and medical care may buffer or worsen that experience. That is not an abstract ideological exercise; it is a conventional epidemiologic and behavioral-health question aimed at a subgroup that may have distinct needs.
What the Evidence Says About the Population
The scientific case for studying sexual and gender minority people in pregnancy is not speculative. A peer-reviewed review of NIH-funded sexual and gender minority health research found 1,093 unique NIH awards from 2012 through 2022, totaling $491.7 million in first-year funding, which amounted to about 0.8% of the NIH portfolio. Another scoping review of obstetric and perinatal health literature identified 55 studies across 1981 to 2023, showing that the field exists, but is still comparatively thin. In other words, the data landscape is real, yet incomplete; that is exactly the kind of gap NIH is supposed to help fill.
There is also a substantial clinical reason to care. A large study in American Journal of Obstetrics and Gynecology reported higher rates of several obstetrical and birth outcomes among birthing patients in mother-mother partnerships, including postpartum hemorrhage, severe morbidity, and nontransfusion severe morbidity, compared with mother-father partnerships. A separate population-based study found sexual minority women had elevated risks for miscarriage, stillbirth, and very preterm birth in some comparisons. These are not trivial differences. They are the kind of findings that justify asking whether psychological distress, access to affirming care, and social support are part of the mechanism.
How to Read the University of Maryland Study
The University of Maryland description, as reported, suggests a dissertation- or early-career-stage project rather than a large flagship center grant. That distinction matters. Small, focused studies often do the groundwork that later supports larger clinical or intervention trials. The project appears aimed at identifying risk and protective factors rather than testing a treatment, which is a normal and often necessary first step in a field where the underlying experience is under-characterized.
The phrase “sexual and gender minority birthing people” is politically salient, but scientifically it is a population descriptor. It signals that the study is not limited to the old shorthand of heterosexual cisgender women, because pregnancy does not map neatly onto sexual orientation or gender identity. That distinction becomes especially relevant in perinatal mental health, where experiences of stigma, healthcare navigation, family support, and disclosure can shape outcomes. A study that ignores those variables can easily miss what is actually driving distress.
Where the Critique Has Some Force
The strongest criticism in the record is not that such research should never exist, but that the public evidence for this specific award is thin. The criticism points out that the visible description comes mainly through a secondary outlet, while the full NIH abstract, budget justification, protocol, and review summary are not provided in the research package. That is a fair limitation. A serious evaluation of a grant always benefits from the underlying award file, because titles can overstate or understate what a project actually does.
But the absence of the full file is not the same as evidence of misuse. The record does not supply a named contradiction, a documented procedural irregularity, or a primary-source rebuttal showing that NIH’s stated maternal-health mission is being violated here. Nor does it show that the project is misclassified within NIH’s broader SGM-health portfolio. In other words, skepticism about transparency is legitimate; a claim that the project is scientifically illegitimate is not established by the material provided.
Why the Framing Became the Story
This dispute is a textbook example of how a technically ordinary population-health grant becomes politically charged once identity language enters the title. NIH has spent years broadening maternal-health and SGM-health research precisely because those populations have documented disparities and historically poor visibility in biomedical datasets. Supporters see that as overdue correction. Critics see it as ideological sorting. The scientific substance, however, is more pedestrian than the rhetoric suggests: measure distress, identify correlates, compare patterns, and use the result to design better care.
That is why comparisons to other NIH-supported pregnancy studies are useful. NIH has funded mechanism-driven work on the microbiome, preterm labor, STI screening, and maternal morbidity, all of which target narrow questions within reproductive health. The University of Maryland project belongs to that same family of targeted inquiry. It is not unusual because it studies a specific subgroup; it is exactly the sort of study NIH increasingly funds when the subgroup is underrepresented, medically vulnerable, or both.
What This Means for NIH and for Readers
The lasting lesson is that labels are not methods. A grant can sound controversial and still be methodologically routine; it can also sound noble and still be weak. The available evidence here points toward the former: a small, plausibly useful study embedded in an established NIH portfolio that already recognizes maternal-health disparities among sexual and gender minority populations. The public case against it is mostly rhetorical, not evidentiary.
If the question is whether federal research dollars should support studies of psychological distress among sexual and gender minority birthing people, the evidence says yes. If the question is whether this exact award deserves detailed scrutiny of its protocol, budget, and outcomes, that is also yes. But those are different judgments. The first concerns scientific legitimacy; the second concerns transparency and execution. On the record provided, the legitimacy case is solid, and the burden now falls on the usual standards of grant review: precise methods, measurable endpoints, and results that can stand on their own.
Sources:
lifesitenews.com, thecollegefix.com, today.umd.edu, pmc.ncbi.nlm.nih.gov, nih.gov, nichd.nih.gov, reporter.nih.gov, grants.nih.gov, cdn.clinicaltrials.gov



